NCT03045419View on ClinicalTrials.gov

Added Value of Gadoxetic Acid-enhanced Liver MRI

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

December 29, 2009

Primary Completion Date

November 24, 2013

Study Completion Date

December 31, 2016

Conditions
HccDiagnosis
Interventions
PROCEDURE

gadoxetic acid-enhanced liver MRI

liver MRI using a standard dose (0.025mmol/kg) of gadoxetic acid

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT03045419 - Added Value of Gadoxetic Acid-enhanced Liver MRI | Biotech Hunter | Biotech Hunter